"cancer drugs" trang 2 - tải miễn phí từ tailieunhanh
ONCOGENOMICS AND CANCER PROTEOMICS – NOVEL APPROACHES IN BIOMARKERS DISCOVERY AND THERAPEUTIC TARGETS IN CANCER

ONCOGENOMICS AND CANCER PROTEOMICS – NOVEL APPROACHES IN BIOMARKERS DISCOVERY AND THERAPEUTIC TARGETS IN CANCER

238    54    0
Efficacy and safety of target combined chemotherapy in advanced gastric cancer: A meta-analysis and system review

Efficacy and safety of target combined chemotherapy in advanced gastric cancer: A meta-analysis and system review
9    83    1
Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines

Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines
13    80    1
Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: An in-vitro study

Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: An in-vitro study
11    51    1
The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts

The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
9    50    1
Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: An effect mediated by EGFR inhibition, p53 acetylation and oxidative stress

Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: An effect mediated by EGFR inhibition, p53 acetylation and oxidative stress
14    38    1
High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs

High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs
9    59    1
Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells

Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells
12    49    1
DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer

DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer
15    22    1
Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2- low advanced or metastatic gastric cancer: A multicenter real-world study

Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2- low advanced or metastatic gastric cancer: A multicenter real-world study
8    1    1
Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: A multicenter study

Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: A multicenter study
10    89    0
A new approach for prediction of tumor sensitivity to targeted drugs based on functional data

A new approach for prediction of tumor sensitivity to targeted drugs based on functional data
20    29    1
Optimal analysis of the supply of some cancer drugs preparation by dosage at Choray Hospital

Optimal analysis of the supply of some cancer drugs preparation by dosage at Choray Hospital
9    95    0
A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs

A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs
11    34    1
Treatment with anticancer drugs for advanced pancreatic cancer: A systematic review

Treatment with anticancer drugs for advanced pancreatic cancer: A systematic review
16    1    1
Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: A retrospective cohort study

Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: A retrospective cohort study
12    19    1
Ebook Cancer signaling: From molecular biology to targeted therapy

Ebook Cancer signaling: From molecular biology to targeted therapy
357    2    1
Encyclopedia of cancer

Encyclopedia of cancer
586    52    0
ALTERNATIVE TREATMENT FOR CANCER

ALTERNATIVE TREATMENT FOR CANCER
384    56    0
Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells

Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells
13    78    0